Hunterdon Medical Center is a 178-bed non-profit community hospital located in Raritan Township, New Jersey near Flemington. In 2021 it was given a grade A by the Leapfrog patient safety organization.

There are 178 beds in Hunterdon Medical Center.

During the past decade, Hunterdon Medical Center conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 28 clinical trials were completed, i.e. on average, 164.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 13 clinical trials were completed. i.e. 433.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hunterdon Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 25 trials, followed by "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "SWOG Cancer Research Network" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hunterdon Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "NRG Oncology" with 4 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Hunterdon Medical Center" are "Recurrent Melanoma" (4 trials), "Recurrent Breast Carcinoma" (3 trials), "Stage IB Breast Cancer AJCC v7" (3 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials) and "Stage IIA Breast Cancer AJCC v6 and v7" (3 trials). Many other conditions were trialed in "Hunterdon Medical Center" in a lesser frequency.

Most popular intervention types in "Hunterdon Medical Center" are "Drug" (36 trials), "Other" (31 trials), "Biological" (21 trials), "Procedure" (6 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Quality-of-Life Assessment" (11 trials), "Paclitaxel" (10 trials), "Bevacizumab" (9 trials) and "Carboplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Hunterdon Medical Center" are 35 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hunterdon Medical Center". undefined are not yet recruiting, 4 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Hunterdon Medical Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hunterdon Medical Center, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".